What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. In light of that, when we looked at Dr. Soliman Abdel Kader Fakeeh Hospital (TADAWUL:4017) and its ROCE trend, we weren't exactly thrilled.

Return On Capital Employed (ROCE): What Is It?

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Dr. Soliman Abdel Kader Fakeeh Hospital, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.066 = ر.س305m ÷ (ر.س5.7b - ر.س1.1b) (Based on the trailing twelve months to September 2025).

Thus, Dr. Soliman Abdel Kader Fakeeh Hospital has an ROCE of 6.6%. Ultimately, that's a low return and it under-performs the Healthcare industry average of 14%.

In the above chart we have measured Dr. Soliman Abdel Kader Fakeeh Hospital's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for Dr. Soliman Abdel Kader Fakeeh Hospital .

What Can We Tell From Dr. Soliman Abdel Kader Fakeeh Hospital's ROCE Trend?

In terms of Dr. Soliman Abdel Kader Fakeeh Hospital's historical ROCE movements, the trend isn't fantastic. Over the last five years, returns on capital have decreased to 6.6% from 11% five years ago. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. If these investments prove successful, this can bode very well for long term stock performance.

Our Take On Dr. Soliman Abdel Kader Fakeeh Hospital's ROCE

While returns have fallen for Dr. Soliman Abdel Kader Fakeeh Hospital in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. However, despite the promising trends, the stock has fallen 49% over the last year, so there might be an opportunity here for astute investors. As a result, we'd recommend researching this stock further to uncover what other fundamentals of the business can show us.

Dr. Soliman Abdel Kader Fakeeh Hospital could be trading at an attractive price in other respects, so you might find our free intrinsic value estimation for 4017 on our platform quite valuable.

While Dr.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.